Like Aureus Sciences

closed 1/8/2013 via Yahoo, Inc.

Elsevier B.V., acquired Aureus Sciences

synopsis: Elsevier announced the acquisition of Aureus Sciences, a Paris, France based privately held company that provides databases and information tools to pharmaceutical and biotech companies. Aureus Sciences gathers unique and high quality quantitative biological activity data for major therapeutic drug targets.
buyer parent: Reed Elsevier
buyer: Elsevier B.V.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles. "
target: Aureus Sciences
Aureus Sciences provides scientific databases and software applications for researchers involved in the drug discovery and development process.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/29/2010 via PR Newswire

Thomson Scientific & Healthcare, acquired GeneGo Inc.

synopsis: Thomson Reuters announced that it has acquired GeneGo, a leading provider of biology and disease information, analytics, and decision support solutions for pharmaceutical research and development. Effective immediately, GeneGo will become part of the Healthcare & Science business of Thomson Reuters.
buyer parent: Thomson Reuters
buyer: Thomson Scientific & Healthcare (:$964.58)
Thomson Scientific & Healthcare provides integrated information solutions to researchers and librarians, physicians and pharmacists, and other professionals worldwide. "
target: GeneGo Inc.
GeneGo is a leading provider of data mining & analysis solutions in systems biology. GeneGo's data mining tools and databases help to capture and define the underlying biology behind different types of high-throughput experimental data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/22/2016 via PR Newswire

The WIRB-Copernicus Group, acquired CenterWatch, Inc.

synopsis: WIRB-Copernicus Group, one of the world's leading providers of solutions that measurably improve the quality and efficiency of clinical research, announced its acquisition of CenterWatch, the leading provider of clinical trial industry news and information. CenterWatch provides clinical trials information to clinical research professionals.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is one of the world's leading providers of solutions that measurably improve the quality and efficience of clinical research. WCG enables biopharmaceutical companies, Clinical Services Organizations and institutions to accelerate the delivery of new treatments. "
target: CenterWatch, Inc.
CenterWatch is the recognized global leader in providing clinical trials information to a broad and influential spectrum of clinical research professionals ranging from sponsors and CROs, to investigative sites, technology solutions and niche providers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/15/2016 via PR Newswire

The WIRB-Copernicus Group, will purchase Clinical Trial Applications from karmadata

synopsis: WIRB-Copernicus Group, one of the world's leading providers of solutions that measurably improve the quality of clinical research, will acquire from karmadata a suite of proprietary applications designed to facilitate the management of clinical trial data. karmadata is the market leader in clinical trial database and decision support applications.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is one of the world's leading providers of solutions that measurably improve the quality and efficience of clinical research. WCG enables biopharmaceutical companies, Clinical Services Organizations and institutions to accelerate the delivery of new treatments. "
seller: karmadata
Karmadata is able to standardize and link the world's healthcare data ranging from leading open data sources to priva pharmacy and medical claims. Its propriety applications are designed to facilitate the management of clinical trial data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/2/2014 via BusinessWire

Cognigen Corporation merged with Simulations Plus, Inc.,

synopsis: Simulations Plus, Inc., a leading provider of simulation and modeling software for pharmaceutical discovery and development, announced that the Agreement and Plan of Merger with Cognigen Corporation has been closed. Cognigen Corporation was founded in 1993 and has grown to become one of the leading providers of clinical trial data analysis.
buyer: Simulations Plus, Inc. (SLP:$21.09)
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation and modeling software that is licensed to and used in the conduct of drug research by major pharmaceutical, biotechnology, agrochemical, and food industry companies worldwide. "
target: Cognigen Corporation
Cognigen Corporation is one of the leading providers of clinical trial data analysis. The company provides analysis and reports that are tailored to the expectations of regulatory agencies so that reports are submitted in a manner that minimizes follow-up questions from regulators.
price ($mm)
$5.20
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 2/6/2014 via BNC Analysis

Berry Consultants, LLC, will purchase FACTS from Tessella Ltd.

synopsis: Berry Consultants, a statistical consulting company specializing in the Bayesian approach to medical statistics, has reached an agreement with Tessella to acquire 100% ownership of FACTS. FACTS (Fixed and Adaptive Clinical Trial Simulator) is the most powerful, versatile, and fastest clinical trial simulation tool on the market.
buyer: Berry Consultants, LLC
Berry Consultants is a statistical consulting company specializing in the Bayesian approach to medical statistics, an approach that is radically changing the way research is done throughout both device and drug development. "
seller: Tessella Ltd.
FACTS (Fixed and Adaptive Clinical Trial Simulator) is the most powerful, versatile, and fastest clinical trial simulation tool on the market. It allows biostatisticians and clinical teams to rapidly design and compare innovative, advanced, clinical trial designs.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/8/2014 via PR Newswire

Evidera, acquired Archimedes, Inc.

synopsis: Symphony Technology Group (STG), a technology and services-focused private equity firm, and Evidera, a leading provider of evidence-based solutions for the healthcare industry, announced the acquisition of Archimedes, a San Francisco-based healthcare modeling company and wholly owned subsidiary of Kaiser Permanente.
buyer parent: Symphony Technology Group
buyer: Evidera
Evidera provides health economics, outcomes research, market access, data analytics and epidemiology services. Their research and consulting services are driven by world-class science and thought leadership and leverage a unique combination of capabilities. "
target parent: Kaiser Permanente
target: Archimedes, Inc.
Archimedes is a healthcare modeling and analytics organization. With the Archimedes Model at its core, the company enables people to combine real-world healthcare data and simulation data to create compelling and actionable evidence used in individual healthcare decision making.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/27/2013 via PR Newswire

Temis Text Intelligence, acquired i3 Analytics

synopsis: TEMIS, the leading provider of Semantic Content Enrichment solutions for the Enterprise, announced that they have acquired the US-based i3 Analytics. i3 Analytics provides the award-winning Biopharma Navigator, a Software-as-a-Service platform that charts the biopharma landscape based on Life Sciences open data.
buyer: Temis Text Intelligence
In order to develop and market innovative Text Mining Solutions, TEMIS was founded in September 2000 by a team of managers, researchers and consultants from IBM. This skilled team had earlier developed and distributed IBM Text Mining solutions worldwide "
target: i3 Analytics
i3 Analytics is a provider of advanced data analytics and visualization technologies. Their Biopharma Navigator is an analytics tool that allow users to map clinical trials landscapes, scan the horizon for the latest news, and stay current on what researchers are doing.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/5/2010 via Company Press Release

Kenneth Getz, acquired CenterWatch, Inc.

synopsis: Ken Getz, the founder of CenterWatch—an industry-leading clinical trials information services company—along with private equity investors has purchased the company from Jobson Medical Information.
buyer: Kenneth Getz
Ken Getz founded CenterWatch in 1994 and established the company as a leading provider of operating and business information on the $40 billion global clinical trials industry. Getz sold the company to the Thomson Corporation in 1998. "
target parent: Wicks Group of Companies
target: CenterWatch, Inc.
CenterWatch is a trusted source and global destination of clinical trials information for both professionals and patients. CenterWatch provides a wide variety of information services including grant leads for investigative sites, data about the global clinical trials industry and more.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/22/2009 via BusinessWire

Phase Forward, acquired Waban Software

synopsis: Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, announced that it has acquired privately held Waban Software, a leading provider of platform solutions for the automation and compliance of clinical data analysis and reporting, for $14 million in cash.
buyer: Phase Forward (PFWD:$0.00)
Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. The company offers proven solutions for electronic data capture, clinical data management and clinical data analysis and reporting automation and compliance. "
target: Waban Software
Waban Software provides solutions that enable pharmaceutical and biotechnology companies to capture, integrate, manage and analyze life-sciences and clinical trial data.
price ($mm)
$12
rev ($mm)
$4
EBITDA ($mm)
EV / rev
3.5x
EV / EBITDA
closed 12/31/2007 via Berkery

Jobson Medical Information LLC, acquired CenterWatch, Inc.

synopsis: The Thomson Corporation announced the sale of CenterWatch to Jobson Medical Information, a portfolio company of The Wicks Group, LLC. CenterWatch is a trusted source and global leader in providing proprietary data and information about clinical trials to both professionals and patients.
buyer parent: The Wicks Group of Companies, L.L.C.
buyer: Jobson Medical Information LLC
Jobson Medical Information is a leading specialty healthcare communications, publishing, and medical education company. Jobson Medical Information produces a broad range of publications, educational programs, enduring educational materials, live events, symposia and websites. "
target parent: Thomson Corporation
target: CenterWatch, Inc.
CenterWatch is a trusted source and global leader in providing proprietary data and information about clinical trials to both professionals and patients.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/31/2006 via BNC Analysis

Informa plc, acquired Citeline

synopsis: Informa plc, the leading provider of business intelligence and strategic services to the global telecoms and media markets has acquired Citeline, Inc., the leading provider of global clinical trials intelligence to the pharmaceutical industry.
buyer: Informa plc (LSE:INF:$3,694.29)
Informa plc is the leading international provider of specialist information and services for the academic and scientific, professional and commercial business communities. "
target: Citeline
Citeline developes innovative intelligence solutions for pharmaceutical and biotechnology companies. Citeline enhances the competitive position of its clients by providing actionable information about competitors' worldwide clinical development activities.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/21/2019 via BusinessWire

Xcenda, acquired Dymaxium, Inc.

synopsis: Xcenda, a part of AmerisourceBergen, announced the acquisition of Dymaxium, a trusted market access partner specializing in the exchange of evidence and information between payers and life science companies through its FormularyDecisions.com® platform.
buyer parent: AmerisourceBergen Corporation
buyer: Xcenda
Xcenda, part of AmerisourceBergen, is a strategic consultancy with 20+ years of experience applying real-world expertise in health economics and outcomes research, reimbursement, stakeholder insights, and market access consulting and communications. "
target: Dymaxium, Inc.
Dymaxium is a trusted market access partner specializing in the exchange of evidence and information between payers and life science companies through its FormularyDecisions.com® platform.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/7/2016 via BNC Analysis

M3, Inc., will acquire Vidal Group

synopsis: Electra Partners’ portfolio company AXIO Group has received a binding offer from M3 Inc. to purchase Vidal Group, a European provider of reference drug information. Vidal Group provides hospitals, primary care physicians, pharmacists, and patients with on-line access to up-to-date drug databases and related treatment-based information.
buyer: M3, Inc. (TSE:2413:$1,110.45)
M3 Inc. represents the three Ms of Medicine, Media, and Metamorphosis. Their company was founded with the goal of changing the world of medicine through making full use of the power of the Internet. "
target parent: Electra Partners LLP
target: Vidal Group
Vidal Group is a leading European healthcare informatics and information systems company. Vidal Group provides hospitals, primary care physicians, pharmacists, and patients across Europe with on-line access to up-to-date drug databases and related treatment-based information.
price ($mm)
$133
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/30/2016 via BNC Analysis

Affinity Equity Partners, will acquire MedicalDirector

synopsis: Leading Asian private equity firm Affinity Equity Partners agreed to acquire Sydney-based MedicalDirector (formerly Health Communication Network) from Australia’s Primary Health Care Ltd. MedicalDirector is a leading provider of clinical and enterprise software solutions to general practitioners, medical specialists and allied health professionals.
buyer: Affinity Equity Partners
Affinity Equity Partners is an independently-owned buyout fund manager comprising primarily the former investment professionals of UBS Capital Asia Pacific. They are pioneers in buyout investments in the Asia-Pacific region, with an established and widely recognised franchise. "
target parent: Primary Health Care Limited
target: MedicalDirector
MedicalDirector has been supporting healthcare professionals and improving health outcomes for more than 20 years. They provide software for practice management, optimizing patient outcomes, and access to Australia's most comprehensive and up-to-date pharmaceutical database.
price ($mm)
$119
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/26/2015 via Company Press Release

Inovalon, Inc., will acquire Avalere Health LLC

synopsis: Inovalon, a leading technology company providing cloud-based analytics and data-driven intervention platforms to the healthcare industry, has entered into a definitive agreement to acquire Avalere Health, Inc., a leading provider of data-driven advisory services and business intelligence solutions to the pharmaceutical and life sciences industry.
buyer: Inovalon, Inc. (INOV:$449.36)
Inovalon is a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful insight and impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape. "
target: Avalere Health LLC
Avalere Health, Inc. is a leading provider of data-driven advisory services and business intelligence solutions to the pharmaceutical and life sciences industry.
price ($mm)
$140
rev ($mm)
$47
EBITDA ($mm)
EV / rev
3.0x
EV / EBITDA
closed 6/11/2012 via BNC Analysis

Piramal Healthcare Limited, acquired Decision Resources Group

synopsis: Piramal Healthcare Limited has completed its previously announced acquisition of Decision Resources Group, a US based company in the healthcare information segment. Decision Resources Group is a cohesive portfolio of companies that offers best in class, high-value information and insights on important sectors of the healthcare industry.
buyer parent: Piramal Group
buyer: Piramal Healthcare Limited
With assets across North America, Europe and Asia, Piramal Healthcare is one of the largest pharmaceutical custom manufacturing companies across the world. It has significant presence in the global critical care space with sales of anesthesia products to over 100 countries. "
target parent: Providence Equity Partners Inc.
target: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions.
price ($mm)
$635
rev ($mm)
$160
EBITDA ($mm)
EV / rev
4.0x
EV / EBITDA
announced 3/13/2012 via BusinessWire

Certara, will acquire Simcyp Limited

synopsis: Certara has announced the completion of its acquisition of UK-based Simcyp Limited. Simcyp is a leading research company providing a modeling and simulation platform for predicting the fate of drugs in virtual populations, including pediatric populations.
buyer parent: Vector Capital
buyer: Certara
Certara™ is dedicated to improving human health through a broad spectrum of software products and services, from molecular discovery through clinical development, with special focus on supporting translational approaches to drug development. "
target parent: Fusion IP plc
target: Simcyp Limited
Simcyp provides platforms for the modeling and simulation of pharmacokinetics and pharmacodynamics in virtual human populations and virtual laboratory animals (rat, dog and mouse).
price ($mm)
$32
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/22/2010 via Company Press Release

CT Corsearch, acquired Edital

synopsis: CT Corsearch, the premier provider of clearance and protection solutions for trademark and brand professionals, announced it’s acquired Edital, the Questel trademark branch. This acquisition will create best-in-class solutions for managing a brand lifecycle globally—from creation to watching to protecting, maintaining and renewing a brand.
buyer parent: Wolters Kluwer NV
buyer: CT Corsearch
CT Corsearch provides high-quality, intuitive tools and expertise that trademark professionals need to effectively manage the trademark screening, search review and watching processes. "
target parent: Questel
target: Edital
Edital was established in Brussels in 1982 and acquired by Questel, a world leader in Intellectual Property in 2005. Its sole purpose has been to create global solutions for the Intellectual Property professional.
price ($mm)
rev ($mm)
$8
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 7/21/2010 via Company Press Release

MedMeme LLC, acquired Medical Intelligence Solutions

synopsis: MedMeme, LLC, a leading provider of key opinion leader data and competitive intelligence to the healthcare, pharmaceutical, and biotechnical industries, announced the recent acquisition of Medical Intelligence Solutions (MIS), the world's foremost provider of information on medical meeting content.
buyer: MedMeme LLC
MedMeme™ LLC is a medical opinion leader database company serving the pharmaceutical and biotech community worldwide. MedMeme focuses on providing in-depth, comprehensive, accurate, and actionable competitive intelligence on all aspects of medical research and the experts who work in the field. "
target: Medical Intelligence Solutions
Medical Intelligence Solutions (MIS) provides key clinical data presented at domestic and international medical meetings relevant to the development and marketing of pharmaceuticals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/8/2013 via Yahoo, Inc.

Elsevier B.V., acquired Aureus Sciences

synopsis: Elsevier announced the acquisition of Aureus Sciences, a Paris, France based privately held company that provides databases and information tools to pharmaceutical and biotech companies. Aureus Sciences gathers unique and high quality quantitative biological activity data for major therapeutic drug targets.
buyer parent: Reed Elsevier
buyer: Elsevier B.V.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles. "
target: Aureus Sciences
Aureus Sciences provides scientific databases and software applications for researchers involved in the drug discovery and development process.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/27/2019 via PR Newswire

Elsevier B.V., acquired 3D4Medical

synopsis: Elsevier, a global information analytics business specializing in science and health, and part of RELX, has acquired 3D4Medical, the global anatomy education company headquartered in Dublin, Ireland. 3D4Medical's revolutionary cloud-based platform allows users to investigate the details of the human anatomy in incredible 3D.
buyer parent: RELX Group plc
buyer: Elsevier B.V.
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. "
target: 3D4Medical
3D4Medical is the creator of Complete Anatomy, the world’s most advanced 3D anatomy platform. Their revolutionary cloud-based platform allows users to investigate the details of the human anatomy in incredible 3D.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/29/2019 via Company Press Release

Elsevier B.V., will acquire Parity Computing Inc.

synopsis: Elsevier, a global information analytics business specializing in science and health, announced it will acquire Parity Computing Inc., a California-based business that employs artificial intelligence to provide high-accuracy entity resolution, profiling and recommendations for STM content and applications in the world of research.
buyer parent: RELX Group plc
buyer: Elsevier B.V.
Elsevier is a global information analytics business that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions in the areas of strategic research management, R&D performance, and more. "
target: Parity Computing Inc.
Parity Computing Inc. is a California-based business that employs artificial intelligence to provide high-accuracy entity resolution, profiling and recommendations for STM (Scientific, Technical and Medical ) content and applications in the world of research.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/10/2018 via PR Newswire

Elsevier B.V., acquired Aries Systems Corp.

synopsis: Elsevier, the global information analytics business specializing in science and health, announced it has acquired Aries Systems, a leader in scientific publication workflow solutions headquartered outside Boston, MA. Aries' offerings are used for manuscript submission, peer review, production tracking and eCommerce.
buyer parent: RELX Group plc
buyer: Elsevier B.V.
Elsevier is a global information analytics business that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions in the areas of strategic research management, R&D performance, and more. "
target: Aries Systems Corp.
Aries Systems transforms the way scholarly publishers bring high-value content to the world. The company’s innovative and forward-looking workflow solutions manage the complexities of modern print and electronic publishing.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/28/2018 via PR Newswire

Omnicom Health Group, will acquire Elsevier Japan KK

synopsis: Omnicom Health Group will acquire the Pharma Communications business in Japan of Elsevier. Elsevier Japan KK is a leading healthcare communications business in Japan for 38 years, with a reputation for quality delivery of medical content for promotional materials and educational programs directed at doctors and patients.
buyer parent: Omnicom Group Inc.
buyer: Omnicom Health Group (OMC:$15,164.30)
Omnicom Health Group is a global collective of communications companies. It provides marketing services to the health and life-science industries through a combination of specialized agencies, customized client solutions, and collaborations with other Omnicom network agencies. "
target parent: RELX Group plc
target: Elsevier Japan KK
Elsevier Japan KK is a leading healthcare communications business in Japan for 38 years, with a reputation for quality delivery of medical content for promotional materials and educational programs directed at doctors and patients.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/17/2018 via PR Newswire

Elsevier B.V., acquired Via Oncology

synopsis: Elsevier, the information analytics business specializing in science and health, and part of RELX Group, announced that it has acquired Via Oncology, a Pittsburgh, Pennsylvania-based company that provides decision support and best practices in cancer care management.
buyer parent: RELX Group plc
buyer: Elsevier B.V.
Elsevier is a global information analytics business that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions in the areas of strategic research management, R&D performance, and more. "
target parent: UPMC
target: Via Oncology
Via Oncology is a national leader in decision support tools for cancer. The Via Pathways is evidence-based proprietary content developed by committees composed of leading oncologists that forms the basis of clinical algorithms covering 95 percent of cancer types treated in the US.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/2/2017 via PR Newswire

Elsevier B.V., acquired Bepress

synopsis: Elsevier, the global information analytics business specializing in science and health, acquired Bepress, a Berkeley, California-based business that helps academic libraries showcase and share their institutions' research for maximum impact.
buyer parent: RELX Group plc
buyer: Elsevier B.V.
Elsevier is a global information analytics business that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions in the areas of strategic research management, R&D performance, and more. "
target: Bepress
Founded by professors in 1999, Bepress exists to serve academia. Bepress builds hosted solutions that let academic institutions showcase and share their works for maximum impact. The Bepress model is unlimited, cloud-based, and fully hosted, and includes dedicated consulting and support.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/2/2017 via PR Newswire

Elsevier B.V., acquired Plum Analytics

synopsis: Elsevier, a provider of scientific, technical & medical information products & services, announced the acquisition of Plum Analytics from EBSCO Information Services, an information services company providing research & discovery platforms. Plum Analytics is a pioneer in altmetrics, revealing interest & usage of research beyond traditional measures.
buyer parent: RELX Group plc
buyer: Elsevier B.V.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and make groundbreaking discoveries that advance the boundaries of knowledge and human progress."
target parent: EBSCO Industries, Inc.
target: Plum Analytics
Plum Analytics is a pioneer in the field of altmetrics, revealing research interest and usage beyond traditional measures. They help individuals and organizations that use, fund, support, perform, publish or analyze research obtain a broad-spectrum view of interest and usage in research.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/7/2016 via PR Newswire

Elsevier B.V., acquired Hivebench

synopsis: Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced the acquisition of Hivebench, the flagship product of researcher application developer Shazino, based in Lyon, France. Hivebench is a digital laboratory notebook that helps researchers.
buyer parent: RELX Group plc
buyer: Elsevier B.V.
Elsevier is a provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. "
target parent: Shazino
target: Hivebench
Hivebench is a digital laboratory notebook that helps researchers prepare, conduct and analyze experiments, methods, and protocols in one place, saving them valuable time.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/17/2016 via PR Newswire

Elsevier B.V., acquired Social Science Research Network

synopsis: Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced the acquisition of the Social Science Research Network (SSRN). Founded in 1994, SSRN is a Rochester, NY-based scholarly research preprint repository and online community.
buyer parent: RELX Group plc
buyer: Elsevier B.V.
Elsevier is a provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. "
target: Social Science Research Network
Social Science Research Network (SSRN) is a leading social science and humanities repository and online community. SSRN is devoted to the rapid worldwide dissemination of social science research. It currently has over 2 million members and 671,000 paper abstracts from over 300,000 authors.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/1/2015 via PR Newswire

Elsevier B.V., acquired InferMed

synopsis: Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced the acquisition of InferMed, a London-based clinical decision support (CDS) technology company.
buyer parent: RELX Group plc
buyer: Elsevier B.V.
Elsevier is a provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. "
target: InferMed
Formed in 1999 InferMed has become a global leader in providing software and services to the healthcare, pharmaceutical, and clinical research sectors with whom they work in close collaboration.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/12/2015 via PR Newswire

Elsevier B.V., acquired newsflo ltd

synopsis: Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced the acquisition of Newsflo, a London-based company that helps researchers and academic institutions to measure the wider impact of their work by tracking and analyzing media coverage of their publications and findings.
buyer parent: Reed Elsevier
buyer: Elsevier B.V.
Elsevier is a provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. "
target: newsflo ltd
Newsflo monitors and analyses the media impact of individual research papers, researchers and institutions. Developed with leading UK universities, the technology caters to the needs of both researchers and institutions looking to track the media reach of their work.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/7/2015 via Company Press Release

Elsevier B.V., acquired Neoplasia Press Inc.

synopsis: Elsevier, a world-leading provider of scientific, technical and medical information products and solutions, has announced that it has acquired Neoplasia Press Inc. and assumes publication of its flagship journals, Neoplasia and Translational Oncology.
buyer parent: Reed Elsevier
buyer: Elsevier B.V.
Elsevier is a provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. "
target: Neoplasia Press Inc.
Neoplasia is a well-established cancer research journal that publishes the results of novel investigations in all areas of oncology research. Published monthly, Neoplasia features studies describing new molecular and genetic findings relating to the neoplastic phenotype.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/12/2014 via PR Newswire

Elsevier B.V., acquired Amirsys, Inc.

synopsis: Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced the acquisition of Amirsys, a leading provider of innovative healthcare information solutions in radiology, pathology, and anatomy.
buyer parent: Reed Elsevier
buyer: Elsevier B.V.
Elsevier is a provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. "
target: Amirsys, Inc.
Amirsys, Inc. is a leading provider of innovative healthcare information solutions in radiology, pathology, and anatomy. Amirsys delivers medical expertise with powerful technology to provide life-saving, vital information to healthcare professionals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/13/2013 via PR Newswire

Elsevier B.V., acquired Woodhead Publishing Limited

synopsis: Elsevier, a world-leading provider of scientific, technical and medical information products and services, has acquired Woodhead Publishing Limited, a UK-based publisher known for its high-quality content in the fields of materials science, food science, engineering, energy & environmental technology, textile technology and biomedicine.
buyer parent: Reed Elsevier
buyer: Elsevier B.V.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles. "
target: Woodhead Publishing Limited
Woodhead Publishing Ltd. is a leading independent international publishing company. Woodhead publishes in six main subject areas: food science, technology and nutrition; materials engineering; welding and metallurgy; textile technology; environmental technology; finance, commodities and investment.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/7/2013 via BNC Analysis

Elsevier B.V., purchased 32 books from Gulf Publishing Company

synopsis: Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced that it has acquired certain book assets of Gulf Publishing Company (GPC). The portfolio of 32 books includes petroleum engineering titles in drilling, pipeline, oil and gas, and safety.
buyer parent: Reed Elsevier
buyer: Elsevier B.V.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles. "
seller parent: Daily Mail and General Trust plc
seller: Gulf Publishing Company
The portfolio of Gulf Publishing's 32 books are for professionals in upstream oil and gas engineering and cover drilling, recovery methods, reservoir management, processing, and pipeline transmission.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/9/2013 via Company Press Release

Elsevier B.V., acquired Mendeley Limited

synopsis: Elsevier announced the acquisition of Mendeley, a London-based company that operates a global research management and collaboration platform. Researchers worldwide use Mendeley’s desktop and cloud-based tools to manage and annotate documents, create citations and bibliographies, collaborate on research projects and network with fellow academics.
buyer parent: Reed Elsevier
buyer: Elsevier B.V.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles. "
target: Mendeley Limited
Mendeley is a global research collaboration platform and academic database. Mendeley's desktop, mobile and web applications help people to organize, share, and discover new research. Mendeley has grown to 1.9 million users, who have collectively uploaded more than 270 million documents.
price ($mm)
$98
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/8/2013 via Yahoo, Inc.

Elsevier B.V., acquired Aureus Sciences

synopsis: Elsevier announced the acquisition of Aureus Sciences, a Paris, France based privately held company that provides databases and information tools to pharmaceutical and biotech companies. Aureus Sciences gathers unique and high quality quantitative biological activity data for major therapeutic drug targets.
buyer parent: Reed Elsevier
buyer: Elsevier B.V.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles. "
target: Aureus Sciences
Aureus Sciences provides scientific databases and software applications for researchers involved in the drug discovery and development process.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/7/2013 via BNC Analysis

Elsevier B.V., acquired Knovel Corporation

synopsis: Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced the acquisition of Knovel Corp. New York City-based Knovel provides a web-based application that integrates technical information with analytical and search tools to drive innovation and deliver answers engineers can trust.
buyer parent: Reed Elsevier
buyer: Elsevier B.V.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles. "
target parent: Milestone Venture Partners
target: Knovel Corporation
Knovel is a Web-based application integrating technical information with analytical and search tools to drive innovation and deliver answers engineers can trust. Knovel users include thousands of engineers and applied scientists worldwide.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/14/2012 via Folio: First Day

PennWell Corporation, acquired Journal of Emergency Medical Services

synopsis: Tulsa-based PennWell has acquired the Public Safety Group from Elsevier. Included in the deal are the Journal of Emergency Medical Services, the EMS Today Conference & Exposition, FireRescue, Law Officer and associated websites, events, blogs and newsletters.
buyer: PennWell Corporation
Founded in 1910, PennWell Corporation is a privately held and highly diversified business-to-business media and information company that provides quality content and integrated marketing solutions. "
target parent: Reed Elsevier
target: Journal of Emergency Medical Services
Journal of Emergency Medical Services, the most respected journal in the field of emergency services, is published for paramedics, emergency medical technicians, instructors, administrators, nurses and physicians.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/19/2012 via PR Newswire

Elsevier B.V., acquired The Ocular Surface

synopsis: Elsevier, a world-leading provider of scientific, technical and medical information products and services, has acquired The Ocular Surface, a peer-reviewed journal focusing on the external eye and vision. As per January 2012 Elsevier will continue the publication of the quarterly journal.
buyer parent: Reed Elsevier
buyer: Elsevier B.V.
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals and close to 20,000 book titles. "
target: The Ocular Surface
The Ocular Surface, a quarterly, a peer-reviewed journal, is an authoritative resource that integrates and interprets major findings in diverse fields related to the ocular surface, including ophthalmology, optometry, genetics, etc.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/8/2013 via Yahoo, Inc.

Elsevier B.V., acquired Aureus Sciences

synopsis: Elsevier announced the acquisition of Aureus Sciences, a Paris, France based privately held company that provides databases and information tools to pharmaceutical and biotech companies. Aureus Sciences gathers unique and high quality quantitative biological activity data for major therapeutic drug targets.
buyer parent: Reed Elsevier
buyer: Elsevier B.V.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles. "
target: Aureus Sciences
Aureus Sciences provides scientific databases and software applications for researchers involved in the drug discovery and development process.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/13/2013 via PR Newswire

Elsevier B.V., acquired Woodhead Publishing Limited

synopsis: Elsevier, a world-leading provider of scientific, technical and medical information products and services, has acquired Woodhead Publishing Limited, a UK-based publisher known for its high-quality content in the fields of materials science, food science, engineering, energy & environmental technology, textile technology and biomedicine.
buyer parent: Reed Elsevier
buyer: Elsevier B.V.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles. "
target: Woodhead Publishing Limited
Woodhead Publishing Ltd. is a leading independent international publishing company. Woodhead publishes in six main subject areas: food science, technology and nutrition; materials engineering; welding and metallurgy; textile technology; environmental technology; finance, commodities and investment.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 9/16/2015 via BNC Analysis

SAGE Publications, will purchase 19 Journals from Multi-Science Publishing Co Ltd

synopsis: SAGE is delighted to announce that it has acquired the majority of journals owned and published by the independent science and technology publisher, Multi-science. The acquisition results in 19 titles transferring to SAGE as of 2016.
buyer: SAGE Publications
SAGE Publications is a leading international publisher of journals, books, and electronic media for academic, educational, and professional markets. SAGE helps inform and educate a global community of scholars, practitioners, researchers, and students spanning a wide range of subject areas. "
seller: Multi-Science Publishing Co Ltd
Multi-science is an independent publisher of scientific and technology journals, publishing a unique portfolio of journals across engineering, energy and environmental studies, aerospace/aeronautics and sports science.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/28/2017 via BNC Analysis

Edra S.p.A, acquired Grupo Asís Biomedia SL

synopsis: LSWR Group announces that on February 28, 2017, through its subsidiary Edra SpA, they have concluded the acquisition of 100% of the shares of Grupo Asís Biomedia SL, a Spanish company based in Zaragoza and international leader in training, information and communication activities aimed at veterinary professionals.
buyer parent: LSWR Group
buyer: Edra S.p.A
Edra S.p.A. publishes scientific & medical content in the form of books, journals, & drug databases for the healthcare & pharmaceutical sectors in Italy. They operate magazines for Italian pharmacists, as well as a drug information portal for pharmaceutical company professionals. "
target: Grupo Asís Biomedia SL
Grupo Asís Biomedia SL is an international leader in training, information and communication activities aimed at veterinary professionals. Grupo Asís offers its content and services in 61 countries located in five continents, with special attention to Latin America, North America and Europe.
price ($mm)
$4.23
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/13/2016 via PE Hub

Ardian, GHO Capital, acquired Envision Pharma, Inc.

synopsis: Leading middle-market private equity firm, The Halifax Group, announced that it has sold Envision Pharma Group to Ardian and GHO Capital. Envision is a recognized strategic partner for Medical Affairs teams within biopharma, providing scientific data communication services and industry-leading technology solutions.
buyer: Ardian
buyer: GHO Capital
Ardian is an independent private investment company with assets of US$55bn managed or advised in Europe, North America and Asia. Global Healthcare Opportunities, or GHO Capital, was founded in 2014 as a specialist healthcare investment adviser based in London. "
target parent: Halifax Group
target: Envision Pharma, Inc.
Envision is a recognized strategic partner for Medical Affairs teams within biopharma, providing scientific data communication services and industry-leading technology solutions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/19/2013 via BusinessWire

Halifax Group, acquired Envision Pharma, Inc.

synopsis: The Halifax Group, a leading middle-market private equity firm, announced that it has acquired Envision Pharma, Inc. from a subsidiary of Express Scripts Holding Co. Envision is an innovative global technology and scientific communication company focused on the pharmaceutical, biotechnology and medical device industries.
buyer: Halifax Group
The Halifax Group is a private equity firm that invests between $10 and $40 million alongside owners and managers of established, growing and profitable companies that are leaders in their market niche. "
target parent: Express Scripts Inc.
target: Envision Pharma, Inc.
Envision Pharma, founded in 2001, is an innovative global technology and scientific communication company serving pharmaceutical, biotechnology and medical device companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/15/2008 via PR Newswire

United BioSource Corporation, acquired Envision Pharma, Inc.

synopsis: United BioSource Corporation acquired Envision Pharma, a leading scientific communications and technology company. With a focus on the pharmaceutical and biotechnology industry, Envision integrates scientific communication services and targeted software applications.
buyer parent: Oak Investment Partners
buyer: United BioSource Corporation
United BioSource Corporation accelerates the generation, analysis and communication of real world evidence by integrating scientific and operational expertise with innovative technology solutions to support global development and commercialization of medical products for life science companies. "
target: Envision Pharma, Inc.
Envision Pharma is an innovative scientific communications and technology company providing commercially focused, strategically driven scientific and technology solutions to the pharmaceutical, biotechnology and device industries.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/17/2009 via PR Newswire

Pharmaceutical Institute, acquired GeneEd, Inc.

synopsis: Pharmaceutical Institute announced that it has acquired e-learning assets from GeneEd, Inc., a company specializing in life science courseware. These assets, including 155 highly advanced e-courses, help expand Pharmaceutical Institute's already extensive library of training resources.
buyer parent: Campbell Alliance Group, Inc.
buyer: Pharmaceutical Institute
Pharmaceutical Institute is a leading provider of specialized training programs for the pharmaceutical and biotech industry. They partner with subject matter experts from Campbell Alliance, the parent company, to develop highly impactful dstance learning solutions for pharma professionals. "
target: GeneEd, Inc.
GeneEd is a provider of life science e-learning content.Two scientists and a retired venture capitalist founded GeneEd in 1997. Dr. Sunil Maulik and Dr. Salil Patel have more than 15 years of industry and teaching experience at Roche Bioscience, Doubletwist and other life science companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/26/2017 via BNC Analysis

Informa plc, acquired Dove Medical Press Ltd.

synopsis: Events and publishing company Informa announced the acquisition of Dove Medical Press. Dove Medical Press Ltd is a privately held company, with its headquarters in the UK, specializing in the publication of Open Access peer-reviewed journals across the broad spectrum of science, technology and especially medicine.
buyer: Informa plc (LSE:INF:$3,694.29)
Informa is a leading international Business Intelligence, Exhibitions, Events and Academic Publishing Group. It helps commercial, professional and academic communities work smarter and make better decisions faster, through specialist content and intelligence, and opportunities to connect and learn. "
target: Dove Medical Press Ltd.
Dove Medical Press Ltd is a privately held company, with its headquarters in the UK, specializing in the publication of Open Access peer-reviewed journals across the broad spectrum of science, technology and especially medicine.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/19/2016 via PR Newswire

Ritchie Bros. Auctioneers, acquired Mascus

synopsis: Ritchie Bros. Auctioneers Incorporated, the world's largest industrial auctioneer, is pleased to announce that it has acquired Mascus International Holding BV. Mascus is a leading online equipment listing service for used heavy machinery and trucks with the largest online market presence in Europe for heavy machinery and trucks.
buyer: Ritchie Bros. Auctioneers (RBA:$535.53)
Ritchie Bros. is the world's largest seller of used equipment for the construction, transportation, agriculture, material handling, energy, mining, forestry, marine and other industries. Ritchie Bros. TM solutions make it easy for the world's builders to buy and sell equipment with confidence. "
target parent: Vortex Capital Partners
target: Mascus
Mascus is a global leading online equipment listing service for farm machinery, forestry, material handling and grounds care equipment, construction, transportation vehicles and other heavy equipment. Mascus makes trading in used machinery and equipment quicker and more efficient.
price ($mm)
$27
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 5/1/2013 via Yahoo, Inc.

Vortex Capital Partners, will acquire Mascus

synopsis: Alma Media has decided to sell Mascus, an electronic marketplace for trucks, heavy machinery and equipment. Alma Media is selling Mascus to Vortex Capital Partners, a Dutch based venture and expansion capital firm focused on technology companies.
buyer: Vortex Capital Partners
Vortex Capital Partners is an active venture capital firm investing in technology(-enabled) companies in the Benelux. They focus on software, internet, telecoms, semiconductors, infrastructure, technology-enabled services and media. "
target parent: Alma Media Oyj
target: Mascus
Mascus is an electronic marketplace for used construction, agricultural, forest, and groundscare machinery and transportation vehicles. Product ranges include tractors for sale, trailers for sale, used trucks for sale, diggers, box trailers, mini diggers and excavators, etc.
price ($mm)
$14
rev ($mm)
$7
EBITDA ($mm)
EV / rev
2.2x
EV / EBITDA
closed 5/6/2015 via Company Press Release

Springer Science & Business Media merged with Macmillan Science and Education,

synopsis: Holtzbrinck Publishing Group (Holtzbrinck) and BC Partners (BCP) have merged Springer Science+Business Media (owned by funds advised by BCP) in its entirety with the majority of Holtzbrinck-owned Macmillan Science and Education (MSE), namely Nature Publishing Group, Palgrave Macmillan and the global businesses of Macmillan Education.
buyer parent: Verlagsgruppe Georg von Holtzbrinck GmbH
buyer: Macmillan Science and Education
Macmillan Science and Education houses brands that date back to 1843 (Macmillan), 1845 (Scientific American) and 1869 (Nature). Macmillan's businesses create techniques, technology and materials that make learning and discovery easier for students, teachers and researchers. "
target parent: BC Partners
target: Springer Science & Business Media
Springer Science+Business Media is a leading global scientific, technical and medical publisher, providing researchers in academia, scientific institutions and corporate R&D departments with quality content via innovative information products and services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/15/2013 via Company Press Release

BC Partners, acquired Springer Science & Business Media

synopsis: Funds advised by BC Partners, the European private equity firm, together with management has acquired the leading global STM publisher Springer Science+Business Media, from EQT Partners and the Government of Singapore Investment Corporation (“GICIC”) for approximately EUR 3.3 billion including performance components.
buyer: BC Partners
BC Partners is a leading private equity firm that has played an active role in the development of the European buy-out market for over 25 years. BC Partners principally invests in Europe, acquiring and developing European and multinational businesses to create value in partnership with management. "
target parent: EQT
target: Springer Science & Business Media
Springer Science+Business Media is a leading global scientific, technical and medical publisher, providing researchers in academia, scientific institutions and corporate R&D departments with quality content via innovative information products and services.
price ($mm)
$4,423
rev ($mm)
$1,315
EBITDA ($mm)
$457
EV / rev
4.5x
EV / EBITDA
13.0x
closed 2/2/2010 via Capital IQ

EQT Funds Management Limited, Government of Singapore Investment Corporation, acquired Springer Science & Business Media

synopsis: EQT, a leading European private equity fund, and GIC Special Investments, the private equity arm of the Government of Singapore Investment Corporation (“GIC”), have acquired 82% and 18% respectively of Springer Science+Business Media, the world’s second-largest scientific, technical and medical publisher.
buyer: EQT Funds Management Limited (EQT:$561.47)
buyer: Government of Singapore Investment Corporation
EQT is a leading private equity group with operations in in Northern and Eastern Europe and Asia. Government of Singapore Investment Corporation (“GIC”) is a global investment management company established in 1981 to manage Singapore's foreign reserves. "
target parent: Cinven
target: Springer Science & Business Media
Springer Science+Business Media is a publishing company for specialist knowledge and information. They publish textbooks, reference works, databases and provide online services used by both academics, students and practitioners.
price ($mm)
$3,358
rev ($mm)
$1,227
EBITDA ($mm)
$367
EV / rev
2.6x
EV / EBITDA
8.6x
closed 9/16/2003 via BusinessWire

Candover Parters Ltd, Cinven, acquired BertelsmannSpringer

synopsis: Transaction of BertelsmannSpringer legally completes 9/16/03. Cinven and Candover, two of Europe’s leading investment companies, have bought BertelsmannSpringer. As of the Frankfurt Bookfair 2003 to be renamed Springer Science+Business Media.
buyer: Cinven
buyer: Candover Parters Ltd
Cinven is one of Europe's leading private equity providers. Founded in 1977, the firm has been a totally independent business since 1995, focusing entirely on larger European buyouts. "
target parent: Bertelsmann AG
target: BertelsmannSpringer
Springer Science+Business Media is a publishing company for specialist knowledge and information. They publish textbooks, reference works, databases and provide online services used by both academics, students and practitioners.
price ($mm)
$1,086
rev ($mm)
$756
EBITDA ($mm)
$169
EV / rev
1.6x
EV / EBITDA
7.1x
closed 11/6/2018 via BusinessWire

MJH Associates, acquired Medstro & Medtech Boston

synopsis: MJH Associates Inc., a full-service health care communications company has acquired Medstro and MedTech Boston. Medstro is the leading software as a service platform for medicine and health care in three different markets. MedTech Boston is a media brand with three social media handles, an online publication, and a signature annual event.
buyer: MJH Associates
Michael J. Hennessy Associates, Inc (MJH), is the United States’ leading independent provider of integrated communications, education, and research services to the healthcare industry. Its industry-leading network includes digital, broadcast, live, and print communications. "
target: Medstro & Medtech Boston
Medstro is the leading software as a service platform for medicine and health care in three different markets. MedTech Boston is a media brand with three social media handles, an online publication, and a signature annual event.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/21/2016 via PR Web

Pulsus Group Inc., acquired Open Access Journals

synopsis: Medical Publishing Major Pulsus Group takes pleasure in announcing the acquisition of Open access journals with a view to enrich the current research in the field of Medicine.The Pulsus Group Manager, Mr. Abishak, described this as a crucial first step towards strengthening and integrating standard medical publications across the globe.
buyer: Pulsus Group Inc.
Pulsus Group Inc, the medical peer-review publisher, publishes the work of medical researchers in a manner that exemplifies the highest standards in research integrity. "
target: Open Access Journals
Open Access Journals owns and operates a platform that provides free access to scientific literature, journals, and provide source of reference and retrieval to the scholars, amateurs, clinical practitioners and students. The company is based in United Kingdom.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/31/2019 via BusinessWire

MJH Associates, acquired UBM Life Sciences

synopsis: MJH Associates‚ Inc., (MJH) a leading independent full-service health care education, market research and multichannel medical communications company, has acquired media assets from the UBM Life Sciences Group (part of Informa PLC). The assets includes iconic multimedia platforms in the health care, animal care, pharma sciences and dental fields.
buyer: MJH Associates
MJH is the largest full-service medical media company in the U.S. dedicated to delivering trusted health care news across multiple channels. Over 600 MJH associates are dedicated to providing health care professionals with the information and resources they need to optimize patient outcomes. "
target parent: Informa plc
target: UBM Life Sciences
UBM Life Sciences, part of UBM Americas, is a US-based event, information, and marketing services business serving professional communities in human healthcare, veterinary medicine, and the pharmaceutical industry with an unmatched portfolio of in-person, print, and digital products.
price ($mm)
$100
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/11/2018 via PR Newswire

WebMD Corporation, acquired Jobson Healthcare Information

synopsis: WebMD Health Corp., an Internet Brands company and the leader in health information services for consumers and physicians, announced that it has acquired Jobson Healthcare Information (JHI), a leading provider of information, education and marketing services in key healthcare markets.
buyer parent: Kohlberg Kravis Roberts & Co.
buyer: WebMD Corporation (WBMD:$700.55)
WebMD Health Corp., an Internet Brands Company, is the leading provider of health information services, serving patients, physicians, health care professionals, employers, and health plans through their public and private online portals, mobile platforms, and health-focused publications. "
target: Jobson Healthcare Information
Jobson Healthcare Information LLC is a leading healthcare information, education and marketing services company that can reach over one million physicians, pharmacists and eye care professionals with a diversified portfolio of leading multi-channel brands.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/19/2015 via BNC Analysis

Informa plc, acquired Radcliffe Publishing

synopsis: Electric Word, the media and training group, has sold the trade assets of its loss-making subsidiary Radcliffe Publishing to Informa. Radcliffe Publishing is part of the firm’s health division and publishes products to support the education and professional development of doctors, managers and professionals in health.
buyer: Informa plc (LSE:INF:$3,694.29)
Informa provides academics, businesses and individuals with unparalleled knowledge, up-to-the minute information and highly specialist skills and services. With around 7,000 employees working in some 150 offices in over 40 countries, its global reach and breadth of offer is unique. "
target parent: Electric Word Plc
target: Radcliffe Publishing
Radcliffe is a U.K.-based specialist publisher focused on professional development and compliance in primary healthcare. The Radcliffe portfolio extends to professional and academic books, journals, software and open-learning packages covering child health, health education, pharmacy and more.
price ($mm)
$1.43
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like Aureus Sciences


read more

Aureus Sciences

GeneGo Inc.

CenterWatch, Inc.

karmadata

Cognigen Corporation

Tessella Ltd.

Archimedes, Inc.

i3 Analytics

CenterWatch, Inc.

Waban Software

CenterWatch, Inc.

Citeline

Dymaxium, Inc.

Vidal Group

MedicalDirector

Avalere Health LLC

Decision Resources Group

Simcyp Limited

Edital

Medical Intelligence Solutions

read more

Aureus Sciences

read more

3D4Medical

Parity Computing Inc.

Aries Systems Corp.

Elsevier Japan KK

Via Oncology

Bepress

Plum Analytics

Hivebench

Social Science Research Network

InferMed

newsflo ltd

Neoplasia Press Inc.

Amirsys, Inc.

Woodhead Publishing Limited

Gulf Publishing Company

Mendeley Limited

Aureus Sciences

Knovel Corporation

Journal of Emergency Medical Services

The Ocular Surface

read more

Aureus Sciences

Woodhead Publishing Limited

Multi-Science Publishing Co Ltd

Grupo Asís Biomedia SL

Envision Pharma, Inc.

Envision Pharma, Inc.

Envision Pharma, Inc.

GeneEd, Inc.

Dove Medical Press Ltd.

Mascus

Mascus

Springer Science & Business Media

Springer Science & Business Media

Springer Science & Business Media

BertelsmannSpringer

Medstro & Medtech Boston

Open Access Journals

UBM Life Sciences

Jobson Healthcare Information

Radcliffe Publishing

Geography
Matching Companies
Ticker: SLP
 
 
 
 
 
 
 
 
Simulations Plus, Inc.
Simulations Plus, Inc.
Simulations Plus, Inc. is a premier developer of groundbreaking drug discovery and development simulation and modeling software that is licensed to and used in the conduct of drug research by major pharmaceutical, biotechnology, agrochemical, and food industry companies worldwide.
year
2017
rev ($mm)
$21.09
EBITDA ($mm)
$8.59
EBIT ($mm)
$7.51
Net Income ($mm)
$5.26
Employees
62
  • drill down
  • watch
Ticker: DATA
 
 
 
 
 
 
 
 
DATATRAK International, Inc.
DATATRAK International, Inc.
DATATRAK International, Inc. is a worldwide ASP for the EDC industry. The Company provides a suite of software products supporting the use of DATATRAK EDC(TM) and related services to the pharmaceutical, biotechnology, and medical device industries.
year
2012
rev ($mm)
$9.72
EBITDA ($mm)
($1.37)
EBIT ($mm)
($1.53)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: AIM:INS
 
 
 
 
 
 
 
 
Instem
Instem
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide.
year
2019
rev ($mm)
$30.83
EBITDA ($mm)
$4.12
EBIT ($mm)
$3.15
Net Income ($mm)
$2.27
Employees
238
  • drill down
  • watch
Ticker: MDSO
 
 
 
 
 
 
 
 
Medidata Solutions Worldwide
Medidata Solutions Worldwide
Medidata Solutions is a leading global provider of cloud-based clinical development solutions that enhance the efficiency of customers’ clinical trials. Medidata’s advanced platform lowers the total cost of clinical development by optimizing clinical trials from concept to conclusion.
year
2019
rev ($mm)
$660.00
EBITDA ($mm)
$80.64
EBIT ($mm)
$42.88
Net Income ($mm)
$52.74
Employees
1998
  • drill down
  • watch
Ticker: OTCPK:OMCM
 
 
 
 
 
 
 
 
OmniComm Systems, Inc.
OmniComm Systems, Inc.
OmniComm Systems, Inc. is a leading strategic software solutions provider to the life sciences industry. OmniComm is dedicated to helping the world’s pharmaceutical, biotechnology, diagnostic and device firms, and academic medical centers maximize the value of their clinical research investments.
year
2019
rev ($mm)
$24.62
EBITDA ($mm)
$1.80
EBIT ($mm)
$1.31
Net Income ($mm)
$1.83
Employees
175
  • drill down
  • watch
Ticker: NYSE:IQV
 
 
 
 
 
 
 
 
IQVIA
IQVIA
IQVIA Holdings Inc. provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services.
year
2018
rev ($mm)
$10,412.00
EBITDA ($mm)
$1,950.00
EBIT ($mm)
$809.00
Net Income ($mm)
$259.00
Employees
58000
  • drill down
  • watch
Ticker: TSE:2413
 
 
 
 
 
 
 
 
M3.com
M3.com
M3.com is Japan's largest portal site dedicated to healthcare professionals. M3.com provides the latest medical news, overseas journal article summaries, and medical resources. The portal offers information on clinical trials and other services in the healthcare and pharmaceutical industries.
year
2019
rev ($mm)
$1,015.17
EBITDA ($mm)
$288.13
EBIT ($mm)
$275.64
Net Income ($mm)
$175.78
Employees
5165
  • drill down
  • watch
Ticker: ENXTPA:CGM
 
 
 
 
 
 
 
 
Cegedim
Cegedim
Founded in 1969, Cegedim is a global technology and services company specializing in the healthcare field. Cegedim supplies services, technological tools, specialized software, data flow management services and databases.
year
2018
rev ($mm)
$512.82
EBITDA ($mm)
$50.20
EBIT ($mm)
$33.91
Net Income ($mm)
$6.33
Employees
4468
  • drill down
  • watch
Ticker: OMCL
 
 
 
 
 
 
 
 
Omnicell, Inc.
Omnicell, Inc.
Omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire health care continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home.
year
2016
rev ($mm)
$692.62
EBITDA ($mm)
$62.94
EBIT ($mm)
$16.58
Net Income ($mm)
$0.60
Employees
2444
  • drill down
  • watch
Ticker: TRHC
 
 
 
 
 
 
 
 
Tabula Rasa Healthcare
Tabula Rasa Healthcare
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk.
year
2018
rev ($mm)
$204.27
EBITDA ($mm)
$16.27
EBIT ($mm)
$1.63
Net Income ($mm)
Employees
952
  • drill down
  • watch
Ticker: ZMD
 
 
 
 
 
 
 
 
ZoomMed Inc.
ZoomMed Inc.
Zoommed Inc. develops and markets various computer applications for healthcare professionals in Canada. The company builds and operates the ZoomMed Communication Network, a clinical interoperable information exchange network between physicians and various other stakeholders of the healthcare sector.
year
2014
rev ($mm)
$6.08
EBITDA ($mm)
$2.65
EBIT ($mm)
$2.78
Net Income ($mm)
Employees
40
  • drill down
  • watch
Ticker: ASX:MDR
 
 
 
 
 
 
 
 
MedAdvisor Limited
MedAdvisor Limited
MedAdvisor is a world class medication management platform focused on addressing the gap and burden of medication adherence. The highly automated Australian software system connects patients to their local pharmacy, providing them with real time access to their personal medication records.
year
2016
rev ($mm)
$1.05
EBITDA ($mm)
($2.13)
EBIT ($mm)
($2.15)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: TSE:2413
 
 
 
 
 
 
 
 
M3, Inc.
M3 Inc. represents the three Ms of Medicine, Media, and Metamorphosis. Their company was founded with the goal of changing the world of medicine through making full use of the power of the Internet.
year
2019
rev ($mm)
$1,110.45
EBITDA ($mm)
$306.07
EBIT ($mm)
$279.73
Net Income ($mm)
$191.17
Employees
6024
  • drill down
  • watch
Ticker: AIM:MED
 
 
 
 
 
 
 
 
MedaPhor
MedaPhor
MedaPhor is a global provider of advanced ultrasound training simulators for medical professionals. Founded in 2004, they have headquarters in Cardiff, UK and San Diego, USA, and our customers are some of the world's leading medical institutions.
year
2017
rev ($mm)
$5.48
EBITDA ($mm)
($2.09)
EBIT ($mm)
($2.82)
Net Income ($mm)
Employees
31
  • drill down
  • watch
Ticker: TSE:2413
 
 
 
 
 
 
 
 
M3.com
M3.com
M3.com is Japan's largest portal site dedicated to healthcare professionals. M3.com provides the latest medical news, overseas journal article summaries, and medical resources. The portal offers information on clinical trials and other services in the healthcare and pharmaceutical industries.
year
2019
rev ($mm)
$1,015.17
EBITDA ($mm)
$288.13
EBIT ($mm)
$275.64
Net Income ($mm)
$175.78
Employees
5165
  • drill down
  • watch
Ticker: PCSV
 
 
 
 
 
 
 
 
PCS Edventures, Inc.
PCS Edventures, Inc.
PCS Edventures!.com, Inc. is a developer of STEM – science, technology, engineering and mathematics – education products for preschool through college students.
year
2013
rev ($mm)
$2.94
EBITDA ($mm)
($0.42)
EBIT ($mm)
($0.44)
Net Income ($mm)
Employees
19
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
Clarivate Analytics
Clarivate Analytics
Clarivate Analytics is a research analytics software company that provides subscription-based services in research and patent analytics. Organizations and researchers rely on the knowledge bases from Clarivate for information about pharmaceutical and biotech intelligence and IP management.
year
2019
rev ($mm)
$964.58
EBITDA ($mm)
$154.61
EBIT ($mm)
($47.97)
Net Income ($mm)
Employees
4515
  • drill down
  • watch
Ticker: ENXTPA:CGM
 
 
 
 
 
 
 
 
Cegedim
Cegedim
Founded in 1969, Cegedim is a global technology and services company specializing in the healthcare field. Cegedim supplies services, technological tools, specialized software, data flow management services and databases.
year
2018
rev ($mm)
$512.82
EBITDA ($mm)
$50.20
EBIT ($mm)
$33.91
Net Income ($mm)
$6.33
Employees
4468
  • drill down
  • watch
Ticker: NYSE:IQV
 
 
 
 
 
 
 
 
IQVIA
IQVIA
IQVIA Holdings Inc. provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services.
year
2018
rev ($mm)
$10,412.00
EBITDA ($mm)
$1,950.00
EBIT ($mm)
$809.00
Net Income ($mm)
$259.00
Employees
58000
  • drill down
  • watch
Ticker: AIM:CRON
 
 
 
 
 
 
 
 
Cronin Group PLC
Cronin Group PLC provides medical research and development services. The Company focuses on the discovery, development, and manufacture of small molecules and nano-materials utilizing proprietary chemistry. Cronin Group offers its services in the United Kingdom.
year
2018
rev ($mm)
EBITDA ($mm)
($2.29)
EBIT ($mm)
($2.34)
Net Income ($mm)
Employees
25
  • drill down
  • watch
Ticker: TSE:2413
 
 
 
 
 
 
 
 
M3, Inc.
M3 Inc. represents the three Ms of Medicine, Media, and Metamorphosis. Their company was founded with the goal of changing the world of medicine through making full use of the power of the Internet.
year
2019
rev ($mm)
$1,110.45
EBITDA ($mm)
$306.07
EBIT ($mm)
$279.73
Net Income ($mm)
$191.17
Employees
6024
  • drill down
  • watch
Ticker: TSE:6095
 
 
 
 
 
 
 
 
MedPeer,Inc.
MedPeer,Inc.
MedPeer provides appropriate services at every stage of the clinical process physicians are involved in day-to-day clinical operation. Drug Evaluation provides detailed peer reviews of prescription drugs, and Meet the Experts allows members to consult expert physicians in specific therapeutic areas.
year
2016
rev ($mm)
$9.13
EBITDA ($mm)
$0.94
EBIT ($mm)
$0.39
Net Income ($mm)
$0.20
Employees
44
  • drill down
  • watch
Ticker: TMO
 
 
 
 
 
 
 
 
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific Inc. offers an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. They help customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity.
year
2019
rev ($mm)
$24,630.00
EBITDA ($mm)
$6,242.00
EBIT ($mm)
$3,995.00
Net Income ($mm)
$3,174.00
Employees
70000
  • drill down
  • watch